CDKN2B Antikörper (Gly113)
Kurzübersicht für CDKN2B Antikörper (Gly113) (ABIN2891529)
Target
Alle CDKN2B Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Gly113
-
Spezifität
- Human CDKN2B / p15 INK4b
-
Aufreinigung
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide around Gly113 of human CDKN2B / p15 INK4b
Type of Immunogen: Synthetic peptide
-
-
anti-Cyclin-Dependent Kinase Inhibitor 2B (p15, Inhibits CDK4) (CDKN2B) antibody
CDKN2B Reaktivität: Human WB, IHC, IF, IHC (p) Wirt: Maus Monoclonal 8H4 unconjugated
anti-Cyclin-Dependent Kinase Inhibitor 2B (p15, Inhibits CDK4) (CDKN2B) (AA 102-130) antibodyCDKN2B Reaktivität: Human WB, ELISA, IHC, IF, FACS Wirt: Kaninchen Polyclonal unconjugated
anti-Cyclin-Dependent Kinase Inhibitor 2B (p15, Inhibits CDK4) (CDKN2B) antibodyCDKN2B Reaktivität: Human WB, ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Cyclin-Dependent Kinase Inhibitor 2B (p15, Inhibits CDK4) (CDKN2B) (AA 102-130), (C-Term) antibodyCDKN2B Reaktivität: Human WB, IF, FACS, IHC (p) Wirt: Kaninchen Polyclonal RB13822 unconjugated
anti-Cyclin-Dependent Kinase Inhibitor 2B (p15, Inhibits CDK4) (CDKN2B) (Internal Region) antibodyCDKN2B Reaktivität: Human, Maus, Ratte WB, ELISA, IHC, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Cyclin-Dependent Kinase Inhibitor 2B (p15, Inhibits CDK4) (CDKN2B) antibodyCDKN2B Reaktivität: Human WB, IHC, FACS, IHC (p) Wirt: Maus Monoclonal 2D11 unconjugated
anti-Cyclin-Dependent Kinase Inhibitor 2B (p15, Inhibits CDK4) (CDKN2B) (AA 1-130) antibodyCDKN2B Reaktivität: Maus WB, IHC, ICC, IP Wirt: Kaninchen Polyclonal unconjugated
anti-Cyclin-Dependent Kinase Inhibitor 2B (p15, Inhibits CDK4) (CDKN2B) (AA 1-138) antibodyCDKN2B Reaktivität: Human ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Cyclin-Dependent Kinase Inhibitor 2B (p15, Inhibits CDK4) (CDKN2B) (AA 1-138) antibodyCDKN2B Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 8C4 unconjugated
anti-Cyclin-Dependent Kinase Inhibitor 2B (p15, Inhibits CDK4) (CDKN2B) (AA 1-138) antibodyCDKN2B Reaktivität: Human WB, ELISA Wirt: Maus Polyclonal unconjugated
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- PBS, pH 7.2, 0.05 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
-
-
- CDKN2B (Cyclin-Dependent Kinase Inhibitor 2B (p15, Inhibits CDK4) (CDKN2B))
-
Andere Bezeichnung
- CDKN2B / p15 INK4b
-
Hintergrund
-
Name/Gene ID: CDKN2B
Synonyms: CDKN2B, CDK inhibitory protein, CDK4B inhibitor, INK4B, MTS2, Multiple tumor suppressor 2, p14_INK4B, p15, p14_CDK inhibitor, p15 CDK inhibitor, p15 INK4b, p15-INK4b, p15_INK4B, p14-INK4b, p15INK4b, CDK4I, MTS-2, TP15 -
Gen-ID
- 1030
-
UniProt
- P42772
-
Pathways
- Zellzyklus, Mitotic G1-G1/S Phases
Target
-
